Product Reports Resources Pricing Login Book a demo

Pacific Biosciences

Biotech & Life Sciences · Menlo Park, United States · Founded 2004 · IPO 2010

Biotechnology company manufacturing systems for gene sequencing and real-time biological observations

Valuation $861M
Revenue $167M

Talent graph

Pacific Biosciences's talent

Book a demo to see the people
Employees mapped 587 incl. 6 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on Pacific Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage
Kleiner Perkins
Gen-Probe
DAG Ventures
Sutter Hill Ventures
Mohr Davidow Ventures
Big Red Ventures
Maverick Capital
Alloy Ventures
Deerfield
Cornell University
AllianceBernstein
Morgan Stanley
Intel Capital
T. Rowe Price

Global footprint

Where Pacific Biosciences has talent and traffic

Workforce by country
21 countries with
team presence
🇺🇸 United States82.5%
🇬🇧 United Kingdom3%
🇩🇪 Germany2.4%
🇨🇳 China2.3%
🇸🇬 Singapore1.8%
Top 5 of 21 shown
Web traffic by country
18K monthly visits
across markets
🇺🇸 United States101.1%
🇪🇸 Spain1.1%
Top 2 markets shown

Patent intelligence

$314M patent portfolio · 245 active families

Estimated portfolio value
$314M
36.4% of market cap · 7.6× smaller than top peer Illumina ($2.4B)
245 active patent families
Where Pacific Biosciences innovates BioinformaticsBiomedical engineeringBristleComputational biologyCutis

Where Pacific Biosciences concentrates vs peers

Each axis is a top-10 topic across Pacific Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Pacific Biosciences's 3 investments and acquisitions.

Every disclosed deal where Pacific Biosciences appeared as a backer or acquirer, 2021–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Pacific Biosciences's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Pacific Biosciences deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Pacific Biosciences's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Pacific Biosciences

        An AI-synthesized read of the highest-engagement posts about Pacific Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Pacific Biosciences on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.